Watch CBS News
The FDA has announced plans to ban trans fats in all manufactured foods by 2018. Dietitian Keri Glassman tells CBSN's Meg Oliver about the impact officials hope it will have on public health.
An FDA advisory committee voted to approve a new type of cholesterol-lowering drug called alirocumab. As Elaine Quijano explains, the drug has seen success in clinical trials.
The first new approach to fighting cholesterol in three decades could move closer to reality Tuesday, as an FDA advisory panel is set to begin voting on recommending approval. Dr. Tara Narula, cardiologist at Lenox Hill Hospital in New York, joins “CBS This Morning” to explain the potential new approach and explain how it compares to statins.
The so-called "little pink pill" is one step closer to going on the market. After saying no twice, an FDA panel finally recommended the first medication for female sexual dysfunction. However, there are still big questions about the new pill. Dr. Tara Narula joins “CBS This Morning” to discuss the controversy.
An advisory panel voted Thursday to recommend that the FDA approve a drug that boosts a woman's sex drive, despite controversy over the drug's efficacy. CBS News chief medical correspondent Dr. Jon LaPook has details.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 4, 2021, on "Face the Nation."
"CBS This Morning" co-host Gayle King shares her thoughts on Sheryl Sandberg's tribute to her husband, the new sex drug for women that's getting the FDA's attention and a ban on a skinny ad in the U.K. She joins CBSN with more.
The FDA will review a possible new sex drug for women. CBS News medical contributor Dr. Tara Narula joins CBSN with the details.
It's the little pink pill that could lead to increased sexual desire for millions of women. Dr. Tara Narula joins "CBS This Morning" to discuss an unprecedented medical breakthrough that could possibly give women the same libido enhancements men have been enjoying since Viagra and other similar medications hit America's pharmacies.
For the first time in nearly 30 years the government is looking at whether to regulate the natural remedies the way it does over-the-counter drugs. Dr. Holly Phillips joins “CBS This Morning” to discuss the FDA's concerns.
Doctors have a new tool in the fight against heart failure, the condition affecting nearly 5 million Americans. Cardiologist Dr. Tara Narula joins "CBS This Morning" to share details and side effects of the new heart drug.
Public urged against drinking recalled water brand still being sold online and promoted on social media.
Only a handful of people who got the drugmakers' vaccine contracted coronavirus, according to the latest trial.
The FDA issues new warnings over testosterone-boosting drugs. Also, there's newly-developed benefits from coffee. Doctors Jon LaPook and Holly Phillips joins "CBS This Morning: Saturday" to tell us more.
There may be no greater thrill than seeing your baby for the first time. Improving technology is giving expecting mothers a much sharper view of the fetus, but as images get clearer, more women are going for a potentially dangerous option. Dr. Tara Narula reports on how that has some doctors and the FDA waving warning flags.
Some call the pill “female Viagra.” Doctors Jon LaPook and Holly Phillips join “CBS This Morning: Saturday” to speak about a controversial new sex pill for women that’s had trouble getting FDA approval.
The makers of a possible female treatment for women's sexual dysfunction are trying for a third time to win FDA approval. Dr. Tara Narula joins "CBS This Morning" to discuss the debate over sexual health and sexism.
After being rejected twice before, Sprout Pharmaceuticals is trying again to get FDA approval for its sex drive-boosting drug for women. Medical contributor Dr. Tara Narula joins CBSN to discuss the drug.
Did the FDA ignite the opioid epidemic? Then, should a former terrorist be allowed into witness protection? And, China's drive to dominate the electric car industry
About 30 million Americans suffer from eczema. Now, the Food and Drug Administration is fast-tracking Dupilumab -- a new drug treatment that is changing the lives of people with the skin condition. Brian Webb reports.
Stanford University make a breakthrough concerning a common class of antibiotic that can cause hearing loss. And the FDA approves the highest number of drugs in 18 years. Eboni Williams reports on some of the day’s top health stories from New York.
The Food and Drug Administration approved a drug called Saxenda to treat obesity. Also, positive results from an anti-smoking campaign. Omar Villafranca reports on the day's top health news.
The Food and Drug Administration announced that it would recommend changing the ban on gay men donating blood. Also, new information on the dangers of tanning to teens. Eboni Williams reports on the day's top health news.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired March 28, 2021, on "Face the Nation."
CBS News chief medical correspondent Dr. Jon LaPook and CBS News contributor Dr. Holly Phillips weigh in on this year's flu shot, and the FDA's ban on gay men donating blood.
Conservative activist Charlie Kirk died Wednesday after he was shot at an event at Utah Valley University. Officials say a suspect is now in custody.
A person has been arrested in connection with the shooting that killed conservative activist Charlie Kirk, sources said.
Responding to President Trump, Poland's leader said, "we would also wish that the drone attack on Poland was a mistake. But it wasn't."
A U.S. Immigration and Customs Enforcement agent shot and killed a man in northwest suburban Franklin Park Friday morning, Department of Homeland Security officials said.
A U.S. Secret Service agent who wrote a negative social media post about Charlie Kirk has been put on leave, U.S. officials said Friday.
Conservative activist Charlie Kirk was shot and killed on Wednesday while speaking an event at Utah Valley University.
The Trump administration's tariffs are slowly rippling through the economy and starting to push up prices for some products, government data shows.
The Justice Department filed a $125 million lawsuit against Uber, alleging the company discriminates against disabled passengers.
Over 300 lawsuits challenging many of Trump's second-term plans have been winding through federal courts, and a handful may be poised for Supreme Court review.